BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7332038)

  • 1. [Comparative results of the treatment of anxiety in the depressive syndrome with Tolvon, Vivalan and Alival].
    Ivanov V; Popov G
    Agressologie; 1981 Nov; 22(D):29-30. PubMed ID: 7332038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Third-generation antidepressive agents. Experience with 100 cases of primary depression treated with viloxazine, nomifensine and mianserin].
    Faravelli C; Tonini R; Zaccara G; Marchetti G
    Minerva Psichiatr; 1981; 22(2):79-83. PubMed ID: 7266323
    [No Abstract]   [Full Text] [Related]  

  • 3. Do have antidepressants of the second generation anxiolytic properties?
    Kabes J; Dostal T; Balon R
    Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative double-blind study on efficacy and side-effects of trazodone, nomifensine, mianserin in elderly patients.
    Scardigli G; Jans G
    Adv Biochem Psychopharmacol; 1982; 32():229-36. PubMed ID: 7046366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mianserin: review and discussion of its double-blind studies versus nomifensine].
    Montogomery SA; Rani SJ; Roy D; Montgomery DB
    Encephale; 1981; 7(4 Suppl):485-94. PubMed ID: 7032888
    [No Abstract]   [Full Text] [Related]  

  • 6. [A profile of the clinical effectiveness of second generation antidepressive agents].
    Kabes J; Dostal T; Balon R; Papezová H
    Cesk Psychiatr; 1984 Feb; 80(1):12-20. PubMed ID: 6697402
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.
    Montgomery SA; Roy D; Wynne-Willson S; Robinson C; Montgomery DB
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):205S-211S. PubMed ID: 6337608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of mianserin and nomifensine in depressed outpatients.
    Hamouz W; Van Dorth R; Pinder RM; Stulemeijer SM
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):219S-225S. PubMed ID: 6337609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
    Guliamov MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):582-7. PubMed ID: 3716711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersensitivity and nomifensine in depressed patients.
    Montgomery S; Roy D; Montgomery DB
    Adv Biochem Psychopharmacol; 1982; 32():105-11. PubMed ID: 7046359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
    Pöldinger W
    Dtsch Med Wochenschr; 1982 Apr; 107(17):661-5. PubMed ID: 7075479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of depressive anxiety states associated with psychosomatic symptoms. A double-blind multicentre clinical study: mianserin versus melitracen-flupentixol.
    Van Moffaert M; Dierick M; De Meulemeester F; Vereecken A
    Acta Psychiatr Belg; 1983; 83(5):525-39. PubMed ID: 6670581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nomifensine in different depressive syndromes.
    Overall JE
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):85-8. PubMed ID: 6370983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and anxiety: mianserin and nomifensine compared in a double-blind multicentre trial.
    Granier F; Girard M; Schmitt L; Boscredon J; Oules J; Escande M
    Acta Psychiatr Scand Suppl; 1985; 320():67-74. PubMed ID: 2864794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of anxious-depressive syndromes with Mianserin hydrochloride. Statistical evaluation of the data by Student's "t test"].
    Spinetti G; Battezzati P; Costa R
    Minerva Psichiatr; 1985; 26(1):79-86. PubMed ID: 4021776
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixed anxiety/depressive illness in general practice. A therapeutic comparison of nomifensine with fluphenazine/nortriptyline.
    Valle-Jones JC; Craven JR; Wallis TD; Schiff AA
    Acta Psychiatr Scand; 1983 Dec; 68(6):494-500. PubMed ID: 6666645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic effect of viloxazine (Vivalan ICI) in hospitalized depressive patients -- a multicenter study.
    Kabes J; Náhunek K; Molcan J; Hynek K; Dostal T; Svestka J; Faltus F; Caplová T
    Act Nerv Super (Praha); 1978 Dec; 20(4):251-2. PubMed ID: 735719
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
    Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of depressive conditions with viloxazine by the general practitioner].
    Haehn KD
    Fortschr Med; 1985 Apr; 103(15):408-12. PubMed ID: 3997018
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressant therapy: benefits and risks in perspective.
    Burrows GD; Norman TR; Dennerstein L; Davies BM
    Acta Psychiatr Scand Suppl; 1985; 320():43-7. PubMed ID: 3901673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.